9545sek
-3,1 %
Date:2025-08-01Time:18:00:00Latest report:Q2-2025List:Mid CapTicker:BIOG B
Market Cap:9 656 msekEnterprise Value:9 034 msekNet Sales:1 440 msekEarnings:286,6 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:95,45
MA50:102,49
MA200:108,86
Price/MA200:-12,3 %
RSI (14):30,8
Price/MA50:-6,9 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.